The Angelalign patent ruling concerns a feature the clear-aligner maker says it has already discontinued in Europe. In an October 16, 2026 announcement, Angelalign Technology said the Paris Local Division of the Unified Patent Court found that its Torque Ridges feature infringed an Align Technology patent, but that its current European offering remained available following a switch to Pressure Points.
Key Takeaways
- Angelalign says the infringement ruling concerns its discontinued Torque Ridges feature.
- Pressure Points launched in Europe in September 2026 and has replaced Torque Ridges there.
- The company disputes the decision but says it will comply while reviewing its options.
Table of Contents
- What the Angelalign patent ruling covers
- European products already use Pressure Points
- Customer impact and financial exposure
- Conclusion
What the Angelalign patent ruling covers
The court found that Torque Ridges infringed an Align Technology patent relating to repositioning a patient’s teeth according to an orthodontic treatment plan, Angelalign said. The dispute concerns a specific feature used in clear-aligner treatment.
Angelalign said it disagreed with the decision and was examining the court’s reasoning and its available options. It nevertheless committed to complying with the ruling, including the return of any products. The announcement did not confirm an appeal.
| Item | Details |
|---|---|
| Announcement date | October 16, 2026 US dateline; published October 17 in GMT+08:00. |
| Court | Paris Local Division of the Unified Patent Court. |
| Companies involved | Angelalign Technology, listed in Hong Kong as 6699; patent holder Align Technology, ticker ALGN. |
| Financial disclosure | No quantified financial impact was provided in Angelalign’s announcement. |
European products already use Pressure Points
Angelalign’s European product transition announcement says Torque Ridges had already been replaced by Pressure Points, which launched in the European market in September 2026. The company describes the replacement as designed to improve torque control.
That timing underpins Angelalign’s position that the ruling will not interrupt availability of its current European offering. This is the company’s assessment of the operational impact, rather than an independent determination of the replacement feature’s legal status.
Xavier Cherbavaz, Angelalign’s general manager and vice president for Europe, Africa and the Middle East, said the replacement was intended to support controlled force application and tooth contact. The company said orthodontists could continue treatment using Pressure Points with ongoing clinical and technical support.
Customer impact and financial exposure
Angelalign said customers in Spain, the United Kingdom and outside Europe, including the Americas and Asia, were not affected by the ruling.
The announcement did not quantify potential costs or provide an estimate of the financial impact. Its central commercial message was that the product change had already occurred, while its legal response remained under review.
Conclusion
Angelalign’s position rests on having replaced the disputed feature before the ruling. The next development to watch is the company’s choice of legal response following its review; an appeal was not confirmed in the announcement.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
